The mechanism responsible for the decrease in ADAMTS13:AC in patients with advanced cirrhosis may include enhanced consumption due to the degradation of large quantities of VWF [36], inflammatory cytokines [37], and/or ADAMTS13 plasma inhibitors [38]. The gene discussed is ADAMTS13; the disease is Cirrhosis.